News
-

Karen Read Walks Free After Shocking Verdict in Cop Death Trial
Karen Read was acquitted of second-degree murder and manslaughter in the 2022 death of Boston police officer John O’Keefe. With…
Read More » -

A Texas Man, a Trunk Full of Explosives, and a Plan to Hit LA Protests
Grzegorz Vandenberg, 48, faces federal charges for allegedly transporting explosive mortars and fireworks across state lines with plans to attack…
Read More » -

Powell Flags Inflation Risks as Tariff Effects Hit U.S. Prices
Fed Chair Jerome Powell warned that tariffs are beginning to push up prices in key goods sectors. While the Fed…
Read More » -

Coinbase Stock Soars as Senate Passes Landmark Stablecoin Regulation
Coinbase surged over 14% as the Senate passed the GENIUS Act, the first U.S. regulatory framework for stablecoins. Circle soared…
Read More » -

Trump Keeps Iran — and Everyone Else — Guessing on Military Strikes
President Trump won’t confirm whether he’ll strike Iran’s nuclear sites, fueling tension as U.S. military forces amass in the Gulf…
Read More » -

Gonzalo García Seizes Spotlight as Mbappé Misses Real Madrid’s Club World Cup Debut
With Mbappé sidelined by illness, Gonzalo García was thrown into the fire—and didn’t flinch. Xabi Alonso’s Real Madrid made a…
Read More » -

Borrowers Face Longer Wait for Rate Relief as Fed Holds Steady
With inflation still above target and global risks rising, the Federal Reserve is holding off on rate cuts—leaving borrowers facing…
Read More » -

Tariff Anxiety Is Squeezing U.S. Consumers — and Slowing Spending
As tariff concerns rise, U.S. consumers are cutting back on spending and leaning more on credit. A recent TransUnion survey…
Read More » -

SandboxAQ Publishes Massive Molecular Dataset, Backed by Nvidia, to Turbocharge AI Drug Discovery
SandboxAQ, the Nvidia-backed AI and quantum startup, has released a 5.2 million–structure dataset to speed up drug discovery. With GPU-powered…
Read More » -

Why the Dollar’s 2025 Collapse Isn’t Just a Dip — It’s a Redirection
The U.S. dollar is down nearly 10% this year—its worst first-half in almost four decades. But this isn’t panic selling.…
Read More »









